Trends and Forecast for the Global Middle Eastern and North African Active Pharmaceutical Ingredient MarketTrends, opportunities and forecast in Middle Eastern and North African active pharmaceutical ingredient (API) market to 2027 by synthesis type (synthetic chemical, biotech and biologics, plant extracts, fermentation, and others), manufacturer type (captive API and merchant API), therapeutic area (cardiology, oncology, neurology, ophthalmology, orthopedics, pulmonology, aliment, anti-inflammatory, and others ), product form (liquid API and powder API), molecule type (large molecule and smallLucintel's latest market report analyzed that Middle Eastern and North African active pharmaceutical ingredient (API) provides attractive opportunities in cardiology, oncology, neurology, ophthalmology, orthopedics, pulmonology, aliment, anti-inflammatory therapeutic areas. The Middle Eastern and North African active pharmaceutical ingredient (API) market is expected to reach $5.4 billion by 2027 with a CAGR of 7.9%. In this market, synthetic chemical is the largest segment by synthesis type, whereas cardiology is largest by therapeutic area. Increase in the adoption of advanced technologies in API manufacturing, increasing demand for high potency APIs, and increasing adoption of binder for development of peroxide sensitive APIs provides strategic growth path in this market.
Download Brochure of this report by clicking on https://www.lucintel.com/middle-eastern-and-north-african-active-pharmaceutical-ingredient-market.aspx Based on synthesis type, the Middle Eastern and North African active pharmaceutical ingredient (API) market is segmented into synthetic chemical, biotech and biologics, plant extracts, fermentation, and others. The synthetic chemical segment accounted for the largest share of the market in 2021 and is expected to register the highest CAGR during the forecast period, due to continuous research and development activities and growing demand of synthetic chemical APIs in therapeutic areas.
Browse in-depth TOC on “Middle Eastern and North African Active Pharmaceutical Ingredient (API) Market”
71 – Tables
97 – Figures
158 – Pages
The Middle Eastern and North African Active Pharmaceutical Ingredient (API) Market is marked by the presence of several big and small players. Some of the prominent players offering Middle Eastern and North African active pharmaceutical ingredient (API) include Pfizer, Teva Pharmaceutical, GSK, Sun Pharmaceutical, Novartis, Aurobindo, Merck& Co., BASF, Julphar, and AbbVie.
Request Sample Report:
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.
Media Contact
Company Name: Lucintel
Contact Person: Brandon Fitzgerald
Email: Send Email
Phone: 303.775.0751
Address:8951 Cypress Waters Blvd., Suite 160
City: Dallas
State: TEXAS
Country: United States
Website: https://www.lucintel.com/
